title: Midpregnancy serum thromboxane B2 determinations do not predict subsequent adverse pregnancy outcomes.
authors.affiliation: Department of Obstetrics and Gynecology, University of Alabama, Birmingham.
authors.forename: D J
authors.initials: DJ
authors.lastname: Rouse
authors.forename: J C
authors.initials: JC
authors.lastname: Hauth
authors.forename: C R
authors.initials: CR
authors.lastname: Parker
authors.forename: R L
authors.initials: RL
authors.lastname: Goldenberg
mesh_terms: D005260:Female; D005317:Fetal Growth Retardation / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000097:blood; D011225:Pre-Eclampsia / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*; D011256:Pregnancy Outcome; D013929:Thromboxane B2 / Q000097:blood*
chemical_list: D013929:Thromboxane B2